PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $19,558,000 | +10.1% | 19,479,000 | +11.4% | 0.20% | +13.3% |
Q1 2022 | $17,762,000 | -2.0% | 17,479,000 | 0.0% | 0.17% | +2.4% |
Q4 2021 | $18,126,000 | -0.6% | 17,479,000 | 0.0% | 0.17% | +7.6% |
Q3 2021 | $18,244,000 | -12.7% | 17,479,000 | -10.2% | 0.16% | -1.3% |
Q2 2021 | $20,896,000 | -6.6% | 19,454,000 | 0.0% | 0.16% | -15.9% |
Q1 2021 | $22,361,000 | -10.5% | 19,454,000 | 0.0% | 0.19% | +3.3% |
Q4 2020 | $24,979,000 | +13.0% | 19,454,000 | 0.0% | 0.18% | -6.6% |
Q3 2020 | $22,109,000 | -2.2% | 19,454,000 | 0.0% | 0.20% | -13.7% |
Q2 2020 | $22,604,000 | +6.8% | 19,454,000 | 0.0% | 0.23% | -26.1% |
Q1 2020 | $21,156,000 | -10.3% | 19,454,000 | -4.9% | 0.31% | +12.0% |
Q4 2019 | $23,593,000 | +11.0% | 20,454,000 | 0.0% | 0.27% | +1.9% |
Q3 2019 | $21,253,000 | -26.1% | 20,454,000 | -21.1% | 0.27% | -28.5% |
Q2 2019 | $28,748,000 | +7.0% | 25,939,000 | 0.0% | 0.38% | +2.7% |
Q1 2019 | $26,873,000 | -1.7% | 25,939,000 | -5.5% | 0.37% | +11.6% |
Q4 2018 | $27,337,000 | +81.8% | 27,439,000 | +111.0% | 0.33% | +87.4% |
Q3 2018 | $15,034,000 | +16.4% | 13,007,000 | 0.0% | 0.18% | +4.8% |
Q2 2018 | $12,915,000 | +100.0% | 13,007,000 | +88.3% | 0.17% | +98.8% |
Q1 2018 | $6,457,000 | +63.6% | 6,907,000 | +36.0% | 0.08% | +110.0% |
Q4 2017 | $3,946,000 | +60.7% | 5,079,000 | +69.3% | 0.04% | +48.1% |
Q3 2017 | $2,456,000 | – | 3,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|